Costco cold medicine recalled due to possible ‘contamination’
Costco brand cold and flu medicine was pulled from shelves “due to potential contamination with foreign material.”
A notice shared on the retail giant’s website says the Kirkland Signature Severe Cold & Flu Plus Congestion recall involves item number #1729556 with specific lot code P140082, which was sold at select locations in the Midwest and Southeast.
“Out of an abundance of caution, LNK has initiated a recall due to the accidental release and delivery of a specific batch code that was rejected due to potential contamination with foreign material,” the statement said.
The affected OTC drug was purchased by customers between October 30 and November 30, 2024.
COSTCO ISSUES RECALL OF FROZEN WAFFLES, FREEZE-DRIED MEATS DUE TO LISTERIA CONCERN
Consumers are told not to use the remaining lot code products and to return them to Costco for a full refund.
Anyone with problems or concerns is told to contact the manufacturer LNK International Inc. at 1-800-426-9391 or email complaints-inquiries@lnkintl.com.
Fox Business has reached out to Costco for more information.
COSTCO RECALLS SEVERAL ITEMS DUE TO LISTIERIA CONCERN
Ticker | Security | Last | Change | Change % |
---|---|---|---|---|
CHARGE | COSTCO WHOLESALE CORP. | 916.58 | +6.77 |
+0.74% |
Last month, 8,640 boxes of Kirkland’s Severe Cold & Flu Plus Day and Night Packs were shipped reminds the Administration for Food and Medicines (FDA) because the oral ingredient phenylephrine was deemed “ineffective” as a nasal decongestant after “extensive review.”
“This chemical has been shown to be ineffective against colds and flu in its oral form, except at a dose that has some cardiac toxicity and can lead to palpitations, arrhythmia and high blood pressure,” Dr. Marc Siegel, senior medical analyst for Fox News, said.
CLICK HERE TO READ MORE ABOUT FOX BUSINESS
The December recalled boxes of Kirkland Cold & Flu products had batch numbers P139953 or P139815 with an expiration date of August 2026.
Fox News’ Angelica Stabile contributed to this report.